Added to YB: 2025-02-11
Pitch date: 2025-02-10
GXI.DE [neutral]
Gerresheimer AG
-65.01%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.
Market Cap
EUR 856.6M
Pitch Price
EUR 80.13
Price Target
N/A
Dividend
0.16%
EV/EBITDA
7.56
P/E
36.68
EV/Sales
1.35
Sector
Life Sciences Tools and Services
Category
special_situation
Gerresheimer (GXI) Takeover talks heating up
GXI.DE (overview): Takeover talks w/ PE for whole co, not just glass unit. Shifting to high-value solutions, GLP-1 market upside. Double-digit organic growth goal. Near-term headwinds: destocking, missed expectations. Q1 challenges persist. Bormioli deal may dilute 2025 growth target. M&A upside, but operational issues remain.
Read full article (1 min)